MLICM
SCMP

Metropolitan Life Insurance Company (MetLife)’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-8,854
Closed -$159K – 2539
2017
Q4 		$159K Sell
8,854
-8,781
-50% -$108K ﹤0.01% 2041
2017
Q3 		$208K Hold
17,635
– – ﹤0.01% 2251
2017
Q2 		$185K Hold
17,635
– – ﹤0.01% 2379
2017
Q1 		$194K Hold
17,635
– – ﹤0.01% 2288
2016
Q4 		$239K Buy
17,635
+1,922
+12% +$26.8K ﹤0.01% 2242
2016
Q3 		$193K Sell
15,713
-2,561
-14% -$30.2K ﹤0.01% 2359
2016
Q2 		$200K Hold
18,274
– – ﹤0.01% 2323
2016
Q1 		$200K Hold
18,274
– – ﹤0.01% 2175
2015
Q4 		$316K Hold
18,274
– – ﹤0.01% 1921
2015
Q3 		$363K Buy
18,274
+2,321
+15% +$53.2K ﹤0.01% 1854
2015
Q2 		$262K Buy
15,953
+745
+5% +$12.9K ﹤0.01% 2217
2015
Q1 		$237K Hold
15,208
– – ﹤0.01% 1978
2014
Q4 		$217K Buy
+15,208
New +$161K ﹤0.01% 2361

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s SCMP Position: Q1 2018 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 8,854 shares — an estimated $159K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in SCMP in Q4 2014 and held it in 13 quarters. The position peaked at $363K in Q3 2015. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 8,854 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $159K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2014 and held it in 13 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Sucampo Pharmaceuticals, Inc. position peaked at $363K in Q3 2015.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2018, filed 15 May 2018.